India Transdermal Drug Delivery Systems Market Size & Outlook

The transdermal drug delivery systems market in India is expected to reach a projected revenue of US$ 3,254.7 million by 2030. A compound annual growth rate of 12.5% is expected of India transdermal drug delivery systems market from 2024 to 2030.
Revenue, 2023 (US$M)
$1,428.0
Forecast, 2030 (US$M)
$3,254.7
CAGR, 2024 - 2030
12.5%
Report Coverage
India

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

India transdermal drug delivery systems market, 2018-2030 (US$M)

India transdermal drug delivery systems market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

India transdermal drug delivery systems market highlights

  • The India transdermal drug delivery systems market generated a revenue of USD 1,428.0 million in 2023 and is expected to reach USD 3,254.7 million by 2030.
  • The India market is expected to grow at a CAGR of 12.5% from 2024 to 2030.
  • In terms of segment, iontophoresis was the largest revenue generating technology in 2023.
  • Radio Frequency is the most lucrative technology segment registering the fastest growth during the forecast period.


Transdermal drug delivery systems market data book summary

Market revenue in 2023USD 1,428.0 million
Market revenue in 2030USD 3,254.7 million
Growth rate12.5% (CAGR from 2024 to 2030)
Largest segmentIontophoresis
Fastest growing segmentRadio Frequency
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationElectroporation, Radio Frequency, Iontophoresis, Microporation, Thermal, Mechanical arrays, Ultrasound
Key market players worldwideNovartis AG ADR, Johnson & Johnson, Boehringer Ingelheim, Hisamitsu Pharmaceutical Co Inc, 3M Co, AbbVie Inc


Other key industry trends

  • In terms of revenue, India accounted for 2.3% of the global transdermal drug delivery systems market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, Japan transdermal drug delivery systems market is projected to lead the regional market in terms of revenue in 2030.
  • Australia is the fastest growing regional market in Asia Pacific and is projected to reach USD 852.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Transdermal Drug Delivery Systems Market Companies

Name Profile # Employees HQ Website
4P Therapeutics View profile 11-50 Peachtree City, Georgia, United States, North America http://www.4ptherapeutics.com/
Grünenthal View profile 1001-5000 Puteaux, Ile-de-France, France, Europe https://www.grunenthal.fr
Mylan View profile 10001+ https://www.mylan.in/
Hisamitsu Pharmaceutical Co Inc View profile 3682 408 Tashiro Daikan-machi, Tosu, Saga, Japan, 841-0017 http://www.hisamitsu.co.jp
Boehringer Ingelheim View profile 10001+ Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe https://www.boehringer-ingelheim.com/
3M Co View profile 85000 3M Center, St. Paul, MN, United States, 55144 https://www.3m.com
AbbVie Inc View profile 50000 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 http://www.abbvieinvestor.com
Novartis AG ADR View profile 76057 Lichtstrasse 35, Basel, Switzerland, 4056 https://www.novartis.com
Johnson & Johnson View profile 134400 One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 https://www.jnj.com

India transdermal drug delivery systems market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to transdermal drug delivery systems market will help companies and investors design strategic landscapes.


Iontophoresis was the largest segment with a revenue share of 13.87% in 2023. Horizon Databook has segmented the India transdermal drug delivery systems market based on electroporation, radio frequency, iontophoresis, microporation, thermal, mechanical arrays, ultrasound covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to India transdermal drug delivery systems market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of India transdermal drug delivery systems market databook

  • Our clientele includes a mix of transdermal drug delivery systems market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the India transdermal drug delivery systems market , including forecasts for subscribers. This country databook contains high-level insights into India transdermal drug delivery systems market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

India transdermal drug delivery systems market size, by electroporation, 2018-2030 (US$M)

India Transdermal Drug Delivery Systems Market Outlook Share, 2023 & 2030 (US$M)

India transdermal drug delivery systems market size, by electroporation, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online